Syndax Pharmaceuticals Names Aaron Ondrey CFO, Goldan to Retire
Syndax will appoint Aaron A. Ondrey as CFO on November 9, 2026, succeeding Keith A. Goldan, who will retire and serve as an advisor during an interim period.
Syndax will appoint Aaron A. Ondrey as CFO on November 9, 2026, succeeding Keith A. Goldan, who will retire and serve as an advisor during an interim period.